Can Sitagliptin slow the progression of diabetic retinopathy by reducing inflammation and oxidative stress in retinal tissues?
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Sitagliptin has not been directly linked to slowing diabetic retinopathy progression through reducing retinal inflammation and oxidative stress. Further research is needed.